If you read the article, you will see the large paragraph outlining the dozens of in-person meetings and hundreds of emails that the FDA has exchanged with 23andMe.

What you are noticing is a government agency that has exercised restraint for years, not one that was aloof.

It's generally considered good form to read the article before posting. It's clear from the notice that the FDA known about 23andMe from the outset.